William Fraser Symmans

43PUBLICATIONS
362CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersLiquid biopsiesChemotherapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 22, 2026
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.

|May 26, 2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.

|Mar 14, 2026
Pre-analytical Best Practices for RNA Sequencing from Small Biopsies and Cytologic Specimens.

Gloria Hopkins Sura, Kelly B Engel, Sarah R Greytak

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Apr 11, 2025
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

David J Winchester, Lavisha Singh, Stephen B Edge

Pageof 8

Frequent Collaborators

9 joint publications

Angela M DeMichele

8 joint publications

Laura van 't Veer

8 joint publications

Laura J Esserman

7 joint publications

Gillian L Hirst